| 000 | 01486 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250513202307.0 | ||
| 264 | 0 | _c20000330 | |
| 008 | 200003s 0 0 eng d | ||
| 022 | _a0305-7453 | ||
| 024 | 7 |
_a10.1093/jac/45.2.231 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aThangaraj, H S | |
| 245 | 0 | 0 |
_aIn vitro activity of ciprofloxacin, sparfloxacin, ofloxacin, amikacin and rifampicin against Ghanaian isolates of Mycobacterium ulcerans. _h[electronic resource] |
| 260 |
_bThe Journal of antimicrobial chemotherapy _cFeb 2000 |
||
| 300 |
_a231-3 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAmikacin _xpharmacology |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
| 650 | 0 | 4 |
_aAnti-Infective Agents _xpharmacology |
| 650 | 0 | 4 | _aFluoroquinolones |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeprostatic Agents _xpharmacology |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 |
_aMycobacterium Infections, Nontuberculous _xmicrobiology |
| 650 | 0 | 4 |
_aMycobacterium ulcerans _xdrug effects |
| 650 | 0 | 4 |
_aRifampin _xpharmacology |
| 650 | 0 | 4 | _aUganda |
| 700 | 1 | _aAdjei, O | |
| 700 | 1 | _aAllen, B W | |
| 700 | 1 | _aPortaels, F | |
| 700 | 1 | _aEvans, M R | |
| 700 | 1 | _aBanerjee, D K | |
| 700 | 1 | _aWansbrough-Jones, M H | |
| 773 | 0 |
_tThe Journal of antimicrobial chemotherapy _gvol. 45 _gno. 2 _gp. 231-3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/jac/45.2.231 _zAvailable from publisher's website |
| 999 |
_c10615426 _d10615426 |
||